Lu, J.; Tang, Y.; Li, H.; Chen, X.; Qin, P.; Xu, J.; Li, W.; Chen, L.
Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds. Int. J. Mol. Sci. 2025, 26, 2243.
https://doi.org/10.3390/ijms26052243
AMA Style
Lu J, Tang Y, Li H, Chen X, Qin P, Xu J, Li W, Chen L.
Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds. International Journal of Molecular Sciences. 2025; 26(5):2243.
https://doi.org/10.3390/ijms26052243
Chicago/Turabian Style
Lu, Jiani, Yan Tang, Hongtao Li, Xixiang Chen, Pengcheng Qin, Jianrong Xu, Weihua Li, and Lili Chen.
2025. "Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds" International Journal of Molecular Sciences 26, no. 5: 2243.
https://doi.org/10.3390/ijms26052243
APA Style
Lu, J., Tang, Y., Li, H., Chen, X., Qin, P., Xu, J., Li, W., & Chen, L.
(2025). Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds. International Journal of Molecular Sciences, 26(5), 2243.
https://doi.org/10.3390/ijms26052243